カテゴリ： 世界, 医療/バイオ, Market Monitor Global

C型肝炎ウイルス抗原のグローバル市場展望 2023年-2029年：診断用C型肝炎ウイルス抗原、研究用C型肝炎ウイルス抗原

■ 英語タイトル：Hepatitis C Virus Antigens Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC12363）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC12363
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療
■ ページ数：71
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[C型肝炎ウイルス抗原のグローバル市場展望 2023年-2029年：診断用C型肝炎ウイルス抗原、研究用C型肝炎ウイルス抗原]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のC型肝炎ウイルス抗原市場規模と予測を収録しています。・世界のC型肝炎ウイルス抗原市場：売上、2018年-2023年、2024年-2029年
・世界のC型肝炎ウイルス抗原市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のC型肝炎ウイルス抗原市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「診断用C型肝炎ウイルス抗原」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

C型肝炎ウイルス抗原のグローバル主要企業は、Creative Diagnostics、 Roche Diagnostics、 Meridian Bioscience、 Synnovis、 Merck、 Novateinbio、 Thermo Fisher Scientific、 Medix Biochemica、 Treatment Action Group、 Novus Biologcialsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、C型肝炎ウイルス抗原のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のC型肝炎ウイルス抗原市場：タイプ別、2018年-2023年、2024年-2029年
世界のC型肝炎ウイルス抗原市場：タイプ別市場シェア、2022年
・診断用C型肝炎ウイルス抗原、研究用C型肝炎ウイルス抗原

世界のC型肝炎ウイルス抗原市場：用途別、2018年-2023年、2024年-2029年
世界のC型肝炎ウイルス抗原市場：用途別市場シェア、2022年
・医療、科学研究、その他

世界のC型肝炎ウイルス抗原市場：地域・国別、2018年-2023年、2024年-2029年
世界のC型肝炎ウイルス抗原市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるC型肝炎ウイルス抗原のグローバル売上、2018年-2023年
・主要企業におけるC型肝炎ウイルス抗原のグローバル売上シェア、2022年
・主要企業におけるC型肝炎ウイルス抗原のグローバル販売量、2018年-2023年
・主要企業におけるC型肝炎ウイルス抗原のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Creative Diagnostics、 Roche Diagnostics、 Meridian Bioscience、 Synnovis、 Merck、 Novateinbio、 Thermo Fisher Scientific、 Medix Biochemica、 Treatment Action Group、 Novus Biologcials

*************************************************************

・調査・分析レポートの概要
C型肝炎ウイルス抗原市場の定義
市場セグメント
世界のC型肝炎ウイルス抗原市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のC型肝炎ウイルス抗原市場規模
世界のC型肝炎ウイルス抗原市場規模：2022年 VS 2029年
世界のC型肝炎ウイルス抗原市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのC型肝炎ウイルス抗原の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のC型肝炎ウイルス抗原製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：診断用C型肝炎ウイルス抗原、研究用C型肝炎ウイルス抗原
C型肝炎ウイルス抗原のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：医療、科学研究、その他
C型肝炎ウイルス抗原の用途別グローバル売上・予測

・地域別市場分析
地域別C型肝炎ウイルス抗原市場規模 2022年と2029年
地域別C型肝炎ウイルス抗原売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Creative Diagnostics、 Roche Diagnostics、 Meridian Bioscience、 Synnovis、 Merck、 Novateinbio、 Thermo Fisher Scientific、 Medix Biochemica、 Treatment Action Group、 Novus Biologcials
...

This research report provides a comprehensive analysis of the Hepatitis C Virus Antigens market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Hepatitis C Virus Antigens market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Hepatitis C Virus Antigens, challenges faced by the industry, and potential opportunities for market players.
The global Hepatitis C Virus Antigens market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Hepatitis C Virus Antigens market presents opportunities for various stakeholders, including Medical, Scientific Research. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Hepatitis C Virus Antigens market. Additionally, the growing consumer demand present avenues for market expansion.
The global Hepatitis C Virus Antigens market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Hepatitis C Virus Antigens market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Hepatitis C Virus Antigens market.
Market Overview: The report provides a comprehensive overview of the Hepatitis C Virus Antigens market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Hepatitis C Virus Antigens for Diagnostics, Hepatitis C Virus Antigens for Research), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Hepatitis C Virus Antigens market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Hepatitis C Virus Antigens market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Hepatitis C Virus Antigens market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Hepatitis C Virus Antigens market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Hepatitis C Virus Antigens market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Hepatitis C Virus Antigens market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Hepatitis C Virus Antigens, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Hepatitis C Virus Antigens market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Hepatitis C Virus Antigens market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Hepatitis C Virus Antigens for Diagnostics
Hepatitis C Virus Antigens for Research
Market segment by Application
Medical
Scientific Research
Others
Global Hepatitis C Virus Antigens Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Creative Diagnostics
Roche Diagnostics
Meridian Bioscience
Synnovis
Merck
Novateinbio
Thermo Fisher Scientific
Medix Biochemica
Treatment Action Group
Novus Biologcials
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hepatitis C Virus Antigens, market overview.
Chapter 2: Global Hepatitis C Virus Antigens market size in revenue and volume.
Chapter 3: Detailed analysis of Hepatitis C Virus Antigens manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hepatitis C Virus Antigens in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hepatitis C Virus Antigens capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Hepatitis C Virus Antigens Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis C Virus Antigens Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis C Virus Antigens Overall Market Size
2.1 Global Hepatitis C Virus Antigens Market Size: 2022 VS 2029
2.2 Global Hepatitis C Virus Antigens Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Hepatitis C Virus Antigens Sales: 2018-2029
3 Company Landscape
3.1 Top Hepatitis C Virus Antigens Players in Global Market
3.2 Top Global Hepatitis C Virus Antigens Companies Ranked by Revenue
3.3 Global Hepatitis C Virus Antigens Revenue by Companies
3.4 Global Hepatitis C Virus Antigens Sales by Companies
3.5 Global Hepatitis C Virus Antigens Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hepatitis C Virus Antigens Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hepatitis C Virus Antigens Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hepatitis C Virus Antigens Players in Global Market
3.8.1 List of Global Tier 1 Hepatitis C Virus Antigens Companies
3.8.2 List of Global Tier 2 and Tier 3 Hepatitis C Virus Antigens Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Hepatitis C Virus Antigens Market Size Markets, 2022 & 2029
4.1.2 Hepatitis C Virus Antigens for Diagnostics
4.1.3 Hepatitis C Virus Antigens for Research
4.2 By Type – Global Hepatitis C Virus Antigens Revenue & Forecasts
4.2.1 By Type – Global Hepatitis C Virus Antigens Revenue, 2018-2023
4.2.2 By Type – Global Hepatitis C Virus Antigens Revenue, 2024-2029
4.2.3 By Type – Global Hepatitis C Virus Antigens Revenue Market Share, 2018-2029
4.3 By Type – Global Hepatitis C Virus Antigens Sales & Forecasts
4.3.1 By Type – Global Hepatitis C Virus Antigens Sales, 2018-2023
4.3.2 By Type – Global Hepatitis C Virus Antigens Sales, 2024-2029
4.3.3 By Type – Global Hepatitis C Virus Antigens Sales Market Share, 2018-2029
4.4 By Type – Global Hepatitis C Virus Antigens Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Hepatitis C Virus Antigens Market Size, 2022 & 2029
5.1.2 Medical
5.1.3 Scientific Research
5.1.4 Others
5.2 By Application – Global Hepatitis C Virus Antigens Revenue & Forecasts
5.2.1 By Application – Global Hepatitis C Virus Antigens Revenue, 2018-2023
5.2.2 By Application – Global Hepatitis C Virus Antigens Revenue, 2024-2029
5.2.3 By Application – Global Hepatitis C Virus Antigens Revenue Market Share, 2018-2029
5.3 By Application – Global Hepatitis C Virus Antigens Sales & Forecasts
5.3.1 By Application – Global Hepatitis C Virus Antigens Sales, 2018-2023
5.3.2 By Application – Global Hepatitis C Virus Antigens Sales, 2024-2029
5.3.3 By Application – Global Hepatitis C Virus Antigens Sales Market Share, 2018-2029
5.4 By Application – Global Hepatitis C Virus Antigens Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Hepatitis C Virus Antigens Market Size, 2022 & 2029
6.2 By Region – Global Hepatitis C Virus Antigens Revenue & Forecasts
6.2.1 By Region – Global Hepatitis C Virus Antigens Revenue, 2018-2023
6.2.2 By Region – Global Hepatitis C Virus Antigens Revenue, 2024-2029
6.2.3 By Region – Global Hepatitis C Virus Antigens Revenue Market Share, 2018-2029
6.3 By Region – Global Hepatitis C Virus Antigens Sales & Forecasts
6.3.1 By Region – Global Hepatitis C Virus Antigens Sales, 2018-2023
6.3.2 By Region – Global Hepatitis C Virus Antigens Sales, 2024-2029
6.3.3 By Region – Global Hepatitis C Virus Antigens Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Hepatitis C Virus Antigens Revenue, 2018-2029
6.4.2 By Country – North America Hepatitis C Virus Antigens Sales, 2018-2029
6.4.3 US Hepatitis C Virus Antigens Market Size, 2018-2029
6.4.4 Canada Hepatitis C Virus Antigens Market Size, 2018-2029
6.4.5 Mexico Hepatitis C Virus Antigens Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Hepatitis C Virus Antigens Revenue, 2018-2029
6.5.2 By Country – Europe Hepatitis C Virus Antigens Sales, 2018-2029
6.5.3 Germany Hepatitis C Virus Antigens Market Size, 2018-2029
6.5.4 France Hepatitis C Virus Antigens Market Size, 2018-2029
6.5.5 U.K. Hepatitis C Virus Antigens Market Size, 2018-2029
6.5.6 Italy Hepatitis C Virus Antigens Market Size, 2018-2029
6.5.7 Russia Hepatitis C Virus Antigens Market Size, 2018-2029
6.5.8 Nordic Countries Hepatitis C Virus Antigens Market Size, 2018-2029
6.5.9 Benelux Hepatitis C Virus Antigens Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Hepatitis C Virus Antigens Revenue, 2018-2029
6.6.2 By Region – Asia Hepatitis C Virus Antigens Sales, 2018-2029
6.6.3 China Hepatitis C Virus Antigens Market Size, 2018-2029
6.6.4 Japan Hepatitis C Virus Antigens Market Size, 2018-2029
6.6.5 South Korea Hepatitis C Virus Antigens Market Size, 2018-2029
6.6.6 Southeast Asia Hepatitis C Virus Antigens Market Size, 2018-2029
6.6.7 India Hepatitis C Virus Antigens Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Hepatitis C Virus Antigens Revenue, 2018-2029
6.7.2 By Country – South America Hepatitis C Virus Antigens Sales, 2018-2029
6.7.3 Brazil Hepatitis C Virus Antigens Market Size, 2018-2029
6.7.4 Argentina Hepatitis C Virus Antigens Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Hepatitis C Virus Antigens Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Hepatitis C Virus Antigens Sales, 2018-2029
6.8.3 Turkey Hepatitis C Virus Antigens Market Size, 2018-2029
6.8.4 Israel Hepatitis C Virus Antigens Market Size, 2018-2029
6.8.5 Saudi Arabia Hepatitis C Virus Antigens Market Size, 2018-2029
6.8.6 UAE Hepatitis C Virus Antigens Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Creative Diagnostics
7.1.1 Creative Diagnostics Company Summary
7.1.2 Creative Diagnostics Business Overview
7.1.3 Creative Diagnostics Hepatitis C Virus Antigens Major Product Offerings
7.1.4 Creative Diagnostics Hepatitis C Virus Antigens Sales and Revenue in Global (2018-2023)
7.1.5 Creative Diagnostics Key News & Latest Developments
7.2 Roche Diagnostics
7.2.1 Roche Diagnostics Company Summary
7.2.2 Roche Diagnostics Business Overview
7.2.3 Roche Diagnostics Hepatitis C Virus Antigens Major Product Offerings
7.2.4 Roche Diagnostics Hepatitis C Virus Antigens Sales and Revenue in Global (2018-2023)
7.2.5 Roche Diagnostics Key News & Latest Developments
7.3 Meridian Bioscience
7.3.1 Meridian Bioscience Company Summary
7.3.2 Meridian Bioscience Business Overview
7.3.3 Meridian Bioscience Hepatitis C Virus Antigens Major Product Offerings
7.3.4 Meridian Bioscience Hepatitis C Virus Antigens Sales and Revenue in Global (2018-2023)
7.3.5 Meridian Bioscience Key News & Latest Developments
7.4 Synnovis
7.4.1 Synnovis Company Summary
7.4.2 Synnovis Business Overview
7.4.3 Synnovis Hepatitis C Virus Antigens Major Product Offerings
7.4.4 Synnovis Hepatitis C Virus Antigens Sales and Revenue in Global (2018-2023)
7.4.5 Synnovis Key News & Latest Developments
7.5 Merck
7.5.1 Merck Company Summary
7.5.2 Merck Business Overview
7.5.3 Merck Hepatitis C Virus Antigens Major Product Offerings
7.5.4 Merck Hepatitis C Virus Antigens Sales and Revenue in Global (2018-2023)
7.5.5 Merck Key News & Latest Developments
7.6 Novateinbio
7.6.1 Novateinbio Company Summary
7.6.2 Novateinbio Business Overview
7.6.3 Novateinbio Hepatitis C Virus Antigens Major Product Offerings
7.6.4 Novateinbio Hepatitis C Virus Antigens Sales and Revenue in Global (2018-2023)
7.6.5 Novateinbio Key News & Latest Developments
7.7 Thermo Fisher Scientific
7.7.1 Thermo Fisher Scientific Company Summary
7.7.2 Thermo Fisher Scientific Business Overview
7.7.3 Thermo Fisher Scientific Hepatitis C Virus Antigens Major Product Offerings
7.7.4 Thermo Fisher Scientific Hepatitis C Virus Antigens Sales and Revenue in Global (2018-2023)
7.7.5 Thermo Fisher Scientific Key News & Latest Developments
7.8 Medix Biochemica
7.8.1 Medix Biochemica Company Summary
7.8.2 Medix Biochemica Business Overview
7.8.3 Medix Biochemica Hepatitis C Virus Antigens Major Product Offerings
7.8.4 Medix Biochemica Hepatitis C Virus Antigens Sales and Revenue in Global (2018-2023)
7.8.5 Medix Biochemica Key News & Latest Developments
7.9 Treatment Action Group
7.9.1 Treatment Action Group Company Summary
7.9.2 Treatment Action Group Business Overview
7.9.3 Treatment Action Group Hepatitis C Virus Antigens Major Product Offerings
7.9.4 Treatment Action Group Hepatitis C Virus Antigens Sales and Revenue in Global (2018-2023)
7.9.5 Treatment Action Group Key News & Latest Developments
7.10 Novus Biologcials
7.10.1 Novus Biologcials Company Summary
7.10.2 Novus Biologcials Business Overview
7.10.3 Novus Biologcials Hepatitis C Virus Antigens Major Product Offerings
7.10.4 Novus Biologcials Hepatitis C Virus Antigens Sales and Revenue in Global (2018-2023)
7.10.5 Novus Biologcials Key News & Latest Developments
8 Global Hepatitis C Virus Antigens Production Capacity, Analysis
8.1 Global Hepatitis C Virus Antigens Production Capacity, 2018-2029
8.2 Hepatitis C Virus Antigens Production Capacity of Key Manufacturers in Global Market
8.3 Global Hepatitis C Virus Antigens Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hepatitis C Virus Antigens Supply Chain Analysis
10.1 Hepatitis C Virus Antigens Industry Value Chain
10.2 Hepatitis C Virus Antigens Upstream Market
10.3 Hepatitis C Virus Antigens Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hepatitis C Virus Antigens Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Hepatitis C Virus Antigens in Global Market
Table 2. Top Hepatitis C Virus Antigens Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Hepatitis C Virus Antigens Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Hepatitis C Virus Antigens Revenue Share by Companies, 2018-2023
Table 5. Global Hepatitis C Virus Antigens Sales by Companies, (Units), 2018-2023
Table 6. Global Hepatitis C Virus Antigens Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Hepatitis C Virus Antigens Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Hepatitis C Virus Antigens Product Type
Table 9. List of Global Tier 1 Hepatitis C Virus Antigens Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis C Virus Antigens Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Hepatitis C Virus Antigens Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Hepatitis C Virus Antigens Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Hepatitis C Virus Antigens Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Hepatitis C Virus Antigens Sales (Units), 2018-2023
Table 15. By Type - Global Hepatitis C Virus Antigens Sales (Units), 2024-2029
Table 16. By Application – Global Hepatitis C Virus Antigens Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Hepatitis C Virus Antigens Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Hepatitis C Virus Antigens Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Hepatitis C Virus Antigens Sales (Units), 2018-2023
Table 20. By Application - Global Hepatitis C Virus Antigens Sales (Units), 2024-2029
Table 21. By Region – Global Hepatitis C Virus Antigens Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Hepatitis C Virus Antigens Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Hepatitis C Virus Antigens Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Hepatitis C Virus Antigens Sales (Units), 2018-2023
Table 25. By Region - Global Hepatitis C Virus Antigens Sales (Units), 2024-2029
Table 26. By Country - North America Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Hepatitis C Virus Antigens Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Hepatitis C Virus Antigens Sales, (Units), 2018-2023
Table 29. By Country - North America Hepatitis C Virus Antigens Sales, (Units), 2024-2029
Table 30. By Country - Europe Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Hepatitis C Virus Antigens Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Hepatitis C Virus Antigens Sales, (Units), 2018-2023
Table 33. By Country - Europe Hepatitis C Virus Antigens Sales, (Units), 2024-2029
Table 34. By Region - Asia Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Hepatitis C Virus Antigens Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Hepatitis C Virus Antigens Sales, (Units), 2018-2023
Table 37. By Region - Asia Hepatitis C Virus Antigens Sales, (Units), 2024-2029
Table 38. By Country - South America Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Hepatitis C Virus Antigens Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Hepatitis C Virus Antigens Sales, (Units), 2018-2023
Table 41. By Country - South America Hepatitis C Virus Antigens Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Hepatitis C Virus Antigens Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Hepatitis C Virus Antigens Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Hepatitis C Virus Antigens Sales, (Units), 2024-2029
Table 46. Creative Diagnostics Company Summary
Table 47. Creative Diagnostics Hepatitis C Virus Antigens Product Offerings
Table 48. Creative Diagnostics Hepatitis C Virus Antigens Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Creative Diagnostics Key News & Latest Developments
Table 50. Roche Diagnostics Company Summary
Table 51. Roche Diagnostics Hepatitis C Virus Antigens Product Offerings
Table 52. Roche Diagnostics Hepatitis C Virus Antigens Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Roche Diagnostics Key News & Latest Developments
Table 54. Meridian Bioscience Company Summary
Table 55. Meridian Bioscience Hepatitis C Virus Antigens Product Offerings
Table 56. Meridian Bioscience Hepatitis C Virus Antigens Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Meridian Bioscience Key News & Latest Developments
Table 58. Synnovis Company Summary
Table 59. Synnovis Hepatitis C Virus Antigens Product Offerings
Table 60. Synnovis Hepatitis C Virus Antigens Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Synnovis Key News & Latest Developments
Table 62. Merck Company Summary
Table 63. Merck Hepatitis C Virus Antigens Product Offerings
Table 64. Merck Hepatitis C Virus Antigens Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Merck Key News & Latest Developments
Table 66. Novateinbio Company Summary
Table 67. Novateinbio Hepatitis C Virus Antigens Product Offerings
Table 68. Novateinbio Hepatitis C Virus Antigens Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Novateinbio Key News & Latest Developments
Table 70. Thermo Fisher Scientific Company Summary
Table 71. Thermo Fisher Scientific Hepatitis C Virus Antigens Product Offerings
Table 72. Thermo Fisher Scientific Hepatitis C Virus Antigens Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Thermo Fisher Scientific Key News & Latest Developments
Table 74. Medix Biochemica Company Summary
Table 75. Medix Biochemica Hepatitis C Virus Antigens Product Offerings
Table 76. Medix Biochemica Hepatitis C Virus Antigens Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Medix Biochemica Key News & Latest Developments
Table 78. Treatment Action Group Company Summary
Table 79. Treatment Action Group Hepatitis C Virus Antigens Product Offerings
Table 80. Treatment Action Group Hepatitis C Virus Antigens Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Treatment Action Group Key News & Latest Developments
Table 82. Novus Biologcials Company Summary
Table 83. Novus Biologcials Hepatitis C Virus Antigens Product Offerings
Table 84. Novus Biologcials Hepatitis C Virus Antigens Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Novus Biologcials Key News & Latest Developments
Table 86. Hepatitis C Virus Antigens Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 87. Global Hepatitis C Virus Antigens Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Hepatitis C Virus Antigens Production by Region, 2018-2023 (Units)
Table 89. Global Hepatitis C Virus Antigens Production by Region, 2024-2029 (Units)
Table 90. Hepatitis C Virus Antigens Market Opportunities & Trends in Global Market
Table 91. Hepatitis C Virus Antigens Market Drivers in Global Market
Table 92. Hepatitis C Virus Antigens Market Restraints in Global Market
Table 93. Hepatitis C Virus Antigens Raw Materials
Table 94. Hepatitis C Virus Antigens Raw Materials Suppliers in Global Market
Table 95. Typical Hepatitis C Virus Antigens Downstream
Table 96. Hepatitis C Virus Antigens Downstream Clients in Global Market
Table 97. Hepatitis C Virus Antigens Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hepatitis C Virus Antigens Segment by Type in 2022
Figure 2. Hepatitis C Virus Antigens Segment by Application in 2022
Figure 3. Global Hepatitis C Virus Antigens Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hepatitis C Virus Antigens Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Hepatitis C Virus Antigens Revenue, 2018-2029 (US$, Mn)
Figure 7. Hepatitis C Virus Antigens Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Hepatitis C Virus Antigens Revenue in 2022
Figure 9. By Type - Global Hepatitis C Virus Antigens Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Hepatitis C Virus Antigens Revenue Market Share, 2018-2029
Figure 11. By Type - Global Hepatitis C Virus Antigens Sales Market Share, 2018-2029
Figure 12. By Type - Global Hepatitis C Virus Antigens Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Hepatitis C Virus Antigens Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Hepatitis C Virus Antigens Revenue Market Share, 2018-2029
Figure 15. By Application - Global Hepatitis C Virus Antigens Sales Market Share, 2018-2029
Figure 16. By Application - Global Hepatitis C Virus Antigens Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Hepatitis C Virus Antigens Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Hepatitis C Virus Antigens Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Hepatitis C Virus Antigens Revenue Market Share, 2018-2029
Figure 20. By Region - Global Hepatitis C Virus Antigens Sales Market Share, 2018-2029
Figure 21. By Country - North America Hepatitis C Virus Antigens Revenue Market Share, 2018-2029
Figure 22. By Country - North America Hepatitis C Virus Antigens Sales Market Share, 2018-2029
Figure 23. US Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Hepatitis C Virus Antigens Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Hepatitis C Virus Antigens Sales Market Share, 2018-2029
Figure 28. Germany Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2029
Figure 29. France Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Hepatitis C Virus Antigens Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Hepatitis C Virus Antigens Sales Market Share, 2018-2029
Figure 37. China Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2029
Figure 41. India Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Hepatitis C Virus Antigens Revenue Market Share, 2018-2029
Figure 43. By Country - South America Hepatitis C Virus Antigens Sales Market Share, 2018-2029
Figure 44. Brazil Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Hepatitis C Virus Antigens Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Hepatitis C Virus Antigens Sales Market Share, 2018-2029
Figure 48. Turkey Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Hepatitis C Virus Antigens Revenue, (US$, Mn), 2018-2029
Figure 52. Global Hepatitis C Virus Antigens Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Hepatitis C Virus Antigens by Region, 2022 VS 2029
Figure 54. Hepatitis C Virus Antigens Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • B型肝炎ウイルスパネル迅速検査キットのグローバル市場展望 2023年-2029年：コロイド金法、免疫測定法、その他
  • ヒト免疫不全ウイルス抗体検出キットのグローバル市場展望 2023年-2029年：免疫クロマトグラフィー、コロイド金免疫クロマトグラフィー、ラテックス法、その他
  • サル痘ウイルス抗原迅速検査キットのグローバル市場展望 2023年-2029年：診断用サル痘ウイルス抗原迅速検査キット、研究用サル痘ウイルス抗原迅速検査キット
  • インフルエンザAウイルス抗原検出キットのグローバル市場展望 2023年-2029年：サンプルサイズ20人、サンプルサイズ40人
  • 世界のC型肝炎ウイルスエンベロープタンパク質E2市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC12363 )"C型肝炎ウイルス抗原のグローバル市場展望 2023年-2029年：診断用C型肝炎ウイルス抗原、研究用C型肝炎ウイルス抗原" (英文：Hepatitis C Virus Antigens Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。